Loading…
Aprea Therapeutics, Inc. is projected to rise to $0.9906 by 2027, a +33% move from its current price of $0.745. APRE is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/11/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.7175 | $0.7455 | $0.7746 | +0.07% |
| Jul 14 | $0.7066 | $0.746 | $0.7875 | +0.13% |
| Jul 15 | $0.6985 | $0.7465 | $0.7977 | +0.20% |
| Jul 16 | $0.6919 | $0.747 | $0.8065 | +0.26% |
| Jul 17 | $0.6861 | $0.7474 | $0.8143 | +0.33% |
| Jul 18 | $0.6809 | $0.7479 | $0.8215 | +0.39% |
| Jul 19 | $0.6763 | $0.7484 | $0.8283 | +0.46% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.6763 | $0.7484 | $0.8283 | +0.46% |
| Week 2 | $0.6514 | $0.7519 | $0.8678 | +0.92% |
| Week 3 | $0.6337 | $0.7553 | $0.9003 | +1.39% |
| Week 4 | $0.6195 | $0.7588 | $0.9294 | +1.85% |
| Week 5 | $0.6077 | $0.7623 | $0.9563 | +2.32% |
| Week 6 | $0.5974 | $0.7658 | $0.9817 | +2.79% |
| Week 7 | $0.5883 | $0.7693 | $1.01 | +3.27% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Aprea Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing novel synthetic lethality-based cancer therapeutics that targets DNA damage response pathways. Its lead product candidates are APR-1051, an orally bioavailable small-molecule inhibitor of WEE1 kinase that is in Phase 1 clinical trial for the treatment of patients with advanced solid tumors with biomarkers and ATRN-119, an ATR inhibitor, which is in Phase 1/2a clinical trial for solid tumor indications.
The company is headquartered in Doylestown, Pennsylvania.
Aprea Therapeutics, Inc. (APRE) is a healthcare stock currently trading at $0.728 with a market cap of $9.01M and a rank of 5162. The near-term forecast for 2026 shows a min price of $0.59, an average price of $0.728, and a max of $1.05, with an ROI of 0% and a Neutral sentiment, suggesting the price may hover around the current level in the short term.
The broader forecast paints a generally bullish multi-year path, with gradual upside into the late 2020s and beyond.
A major floor 27.2% below — a decisive break under it would weaken the trend.
The nearest floor, 7.9% below — buyers have tended to step in here.
The nearest ceiling, 25.0% above — a clean break opens room to run.
A major ceiling 38.6% above — clearing it would confirm fresh momentum.
Key APRE support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of APRE market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.747 | Sell | $0.7466 | Sell |
| MA 10 | $0.7632 | Sell | $0.7558 | Sell |
| MA 20 | $0.7613 | Sell | $0.7682 | Sell |
| MA 50 | $0.8157 | Sell | $0.7959 | Sell |
| MA 100 | $0.8128 | Sell | $0.842 | Sell |
| MA 200 | $0.9611 | Sell | $1.05 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.53 | Neutral |
| Stoch RSI (14) | 24.86 | Neutral |
| CCI (20) | -32.63 | Neutral |
| Williams %R (14) | -83.00 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -10.02 | Sell |
| Bollinger %B (20,2) | 0.39 | Neutral |
| Stochastic %K (14) | 17.00 | Buy |
| TRIX (15) | -0.31 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 38.99 | Neutral |
| Momentum (10) | -0.05 | Sell |
| Aroon Osc (25) | 24.00 | Buy |
| Hull MA (9) | 0.73 | Buy |
| ADX (14) | 10.12 | Neutral |
| ATR (14) | 0.03 | Info |
The 30-day technical picture is Bearish, with RSI(14) at 40. The stock trades below the 50-day simple moving average of $0.8175 and below the 200-day simple moving average of $0.9648, indicating near-term weakness relative to longer-term trends. Key support sits at $0.686 and resistance at $0.931, with a 30-day price range from $0.5625 to $0.9421.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.59 | $0.745 | $1.08 | 0% | Neutral | |
| $0.7591 | $0.9906 | $1.38 | +33% | Bullish | |
| $0.7003 | $0.9521 | $1.40 | +28% | Bullish | |
| $0.7414 | $1.04 | $1.59 | +40% | Bullish | |
| $0.6865 | $0.9959 | $1.57 | +34% | Bullish | |
| $0.6208 | $0.9265 | $1.50 | +24% | Bullish | |
| $0.6595 | $1.01 | $1.67 | +36% | Bullish | |
| $0.7485 | $1.18 | $1.99 | +58% | Bullish | |
| $0.8781 | $1.41 | $2.44 | +90% | Bullish | |
| $0.8773 | $1.45 | $2.55 | +94% | Bullish | |
| $1.01 | $1.85 | $3.51 | +148% | Bullish | |
| $1.33 | $2.95 | $6.26 | +295% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.59 | $0.745 | $0.8742 | +0.00% |
| August 2026 | $0.6215 | $0.7417 | $0.9149 | -0.44% |
| September 2026 | $0.6561 | $0.7909 | $0.9905 | +6.63% |
| October 2026 | $0.6538 | $0.7948 | $1.01 | +0.49% |
| November 2026 | $0.6447 | $0.7895 | $1.01 | -0.67% |
| December 2026 | $0.6754 | $0.8327 | $1.08 | +5.47% |
Click any year to see its month-by-month APRE forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Expect APRE to range from $0.59 to $1.08 through 2026. The $0.745 average target implies a 0% move from current prices. A consolidation phase looks the most probable path here.
The APRE price prediction for 2027 points to an average of $0.9906 (low $0.7591, high $1.38) — a potential gain of +33% on today's $0.745. Momentum favours further upside here.
In 2028, APRE is projected to trade between $0.7003 and $1.40, averaging $0.9521 — a potential gain of +28% from today's $0.745. That is -4% versus the projected 2027 average. Buyers look set to stay in control over this stretch.
Aprea Therapeutics, Inc.'s 2029 outlook centres on $1.04, within a $0.7414 to $1.59 range. That is up +10% on the projected 2028 average. That marks a +40% change versus current levels. Momentum favours further upside here.
By 2030, APRE could reach as high as $1.57, with a base case around $0.9959 and support toward $0.6865 — roughly +34% from $0.745. Buyers look set to stay in control over this stretch.
Expect APRE to range from $0.6208 to $1.50 through 2031. The $0.9265 average target implies a +24% move from current prices. That is -7% versus the projected 2030 average. Momentum favours further upside here.
The APRE price prediction for 2032 points to an average of $1.01 (low $0.6595, high $1.67) — a potential gain of +36% on today's $0.745. Buyers look set to stay in control over this stretch.
In 2033, APRE is projected to trade between $0.7485 and $1.99, averaging $1.18 — a potential gain of +58% from today's $0.745. That is up +16% on the projected 2032 average. Momentum favours further upside here.
Aprea Therapeutics, Inc.'s 2034 outlook centres on $1.41, within a $0.8781 to $2.44 range. That is up +20% on the projected 2033 average. That marks a +90% change versus current levels. Buyers look set to stay in control over this stretch.
By 2035, APRE could reach as high as $2.55, with a base case around $1.45 and support toward $0.8773 — roughly +94% from $0.745. Momentum favours further upside here.
Expect APRE to range from $1.01 to $3.51 through 2040. The $1.85 average target implies a +148% move from current prices. That is up +28% on the projected 2035 average. Buyers look set to stay in control over this stretch.
The APRE price prediction for 2050 points to an average of $2.95 (low $1.33, high $6.26) — a potential gain of +295% on today's $0.745. Momentum favours further upside here.
Investing $1,000 in APRE today (≈ 1,342.281879 APRE) could be worth
$3,953.05
+$2,953.05 (+295%) by 2050 · US Dollar
Based on the average projected APRE price of $2.95 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in APREwould be worth at today's price.
$1,000 invested in APRE on Jul 10, 2025 (≈ 564.971758 APRE) would be worth
$420.9
-$579.1 (-57.9%) today · 0.42× · US Dollar
Based on a APRE entry price of $1.77 vs. today's $0.745.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.741 | $1,005.4 | +0.5% |
| 1 month ago | $0.755 | $986.75 | -1.3% |
| 3 months ago | $0.917 | $812.43 | -18.8% |
| 6 months ago | $0.92 | $809.78 | -19.0% |
| 1 year ago | $1.77 | $420.9 | -57.9% |
| All time (5.0y) ago | $106 | $7.03 | -99.3% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our APRE forecast.
Our base-case forecast reaches $1.50 around 2040.
Implied market cap at $1.50: $18.57M
The multi-year forecast shows bullish sentiment across multiple years, with 2027 at an average of $0.9641 (ROI 32.4%), 2028 at $0.9272 (ROI 27.4%), and 2029 at $1.02 (ROI 39.8%). The 2030 forecast is $0.9644 on average (ROI 32.5%), and the trajectory continues upward toward 2031 with $0.8906, 2032 with $0.9669, and 2033 at $1.12. The later years remain bullish with 2034 at $1.35 (ROI 86%), 2035 at $1.39 (ROI 90.7%), 2040 at $1.75 (ROI 139.9%), and 2050 at $2.79 (ROI 282.8%).
These are estimates, not guarantees, and reflect a path of rising averages and higher upside potential alongside ongoing market and development risks.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.9644 with a minimum of $0.6611 and a maximum of $1.53, and an ROI of 32.5%. The sentiment is bullish.
The long-range forecast indicates bullish sentiment in many years beyond 2026, with the average price rising from $0.728 in 2026 to $2.79 in 2050 and a max of up to $5.98. However, these are estimates and not guarantees.
Yes. The forecast maximum by 2050 is $5.98, which exceeds $5.00.
Current price is $0.728 and market cap is $9.01M.
The 30-day range is $0.5625 to $0.9421.
Aprea Therapeutics, Inc. Community Discussion
0Share your Aprea Therapeutics, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.